Skip to main navigation
Plx Pharma logo

SEC Filing Details

Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Investor Menu
  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Presentations
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Governance
    • Document & Charters
    • Committee Composition
  • Financials
    • SEC Filings
    • Financial Results
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Document Details

Form
4
Filing Date
March 16, 2022
Document Date
March 15, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
PLx Pharma Inc.
Filer
Giordano Natasha

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Print Page
  • RSS Feeds
  • Email Alerts
Plx Pharma logo

Quick Links

  • Privacy Policy
  • Terms and Conditions
  • Site Map
  • Contact Us

Contacts

  • info@plxpharma.com
  • (973) 409-6541
  • (973) 843-6300
  • 9 Fishers Lane, Suite E
    Sparta, NJ 07871

© 2022 PLx Pharma Inc. All rights reserved.